AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $126,745,792 | +21.2% | 2,505,848 | +11.9% | 0.01% | +40.0% |
Q2 2023 | $104,596,385 | +22.5% | 2,240,231 | +0.4% | 0.01% | 0.0% |
Q1 2023 | $85,350,676 | -68.9% | 2,230,807 | -55.4% | 0.01% | -37.5% |
Q4 2022 | $274,106,202 | +1370.0% | 5,001,938 | +813.4% | 0.01% | +700.0% |
Q3 2022 | $18,647,000 | +300.4% | 547,622 | +11.1% | 0.00% | – |
Q2 2022 | $4,657,000 | -73.5% | 492,852 | -60.2% | 0.00% | -100.0% |
Q1 2022 | $17,583,000 | -19.5% | 1,239,117 | +20.0% | 0.00% | 0.0% |
Q4 2021 | $21,840,000 | -15.3% | 1,032,621 | -10.5% | 0.00% | 0.0% |
Q3 2021 | $25,794,000 | -15.4% | 1,154,101 | -6.1% | 0.00% | -50.0% |
Q2 2021 | $30,495,000 | +11.8% | 1,229,140 | +30.8% | 0.00% | 0.0% |
Q1 2021 | $27,271,000 | +27.7% | 940,046 | +13.5% | 0.00% | +100.0% |
Q4 2020 | $21,359,000 | +218.8% | 827,884 | +280.4% | 0.00% | – |
Q3 2020 | $6,700,000 | +43.3% | 217,613 | +16.0% | 0.00% | – |
Q2 2020 | $4,675,000 | +85.7% | 187,590 | +57.9% | 0.00% | – |
Q1 2020 | $2,518,000 | +28.9% | 118,784 | +35.0% | 0.00% | – |
Q4 2019 | $1,953,000 | +23.6% | 88,014 | +26.7% | 0.00% | – |
Q3 2019 | $1,580,000 | – | 69,454 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |